Literature DB >> 3040324

Screening of degradative enzymes from articular cartilage in experimental osteoarthritis.

E Vignon, O Gateau, A Martin, D Hartmann, J Bejui, M C Biol, M T Vanier, P Louisot, M Richard.   

Abstract

Sixteen rabbits were killed 12 weeks after sectioning of the right knee anterior cruciate ligament. The left unoperated knee served as a control. The surface area of fibrillated cartilage from femoral condyles and tibial plateau was evaluated and expressed as a percentage of articular surfaces area. Cartilage from the femoro-patellar surfaces was homogenized for the quantification of several degradative activities, based on the release of digested products. Acid phosphatase, several glycosidases and neutral protease activity from the operated joint cartilage were significantly elevated, while collagenolytic activity was unmodified. The percentage of fibrillated cartilage correlated positively with arylsulfatase, glucosidase and neutral protease but negatively with mannosidase and fucosidase. The results may be consistent with the hypothesis of a sequential degradative process leading to cartilage destruction.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3040324     DOI: 10.1007/BF02201026

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  23 in total

1.  A STUDY OF URINARY AND SERUM LYSOZYME IN PATIENTS WITH RENAL DISEASE.

Authors:  D J PROCKOP; W D DAVIDSON
Journal:  N Engl J Med       Date:  1964-02-06       Impact factor: 91.245

2.  A method for estimating serum acid phosphatase of prostatic origin.

Authors:  W H FISHMAN; F LERNER
Journal:  J Biol Chem       Date:  1953-01       Impact factor: 5.157

3.  Metalloproteases of human articular cartilage that digest cartilage proteoglycan at neutral and acid pH.

Authors:  A I Sapolsky; H Keiser; D S Howell; J F Woessner
Journal:  J Clin Invest       Date:  1976-10       Impact factor: 14.808

4.  Microassay for cathepsin D shows an unexpected effedt of cycloheximide on limb-bone rudiments in organ culture.

Authors:  M B Hille; A J Barrett; J T Dingle; H B Fell
Journal:  Exp Cell Res       Date:  1970-08       Impact factor: 3.905

5.  Cartilage destruction in experimentally induced osteoarthritis.

Authors:  E Vignon; J D Hartmann; G Vignon; B Moyen; M Arlot; G Ville
Journal:  J Rheumatol       Date:  1984-04       Impact factor: 4.666

6.  Articular cartilage, blood serum glycosaminoglycans and glycoproteins in osteoarthritis deformans.

Authors:  N A Yusipova; A S Kriuk
Journal:  Clin Chim Acta       Date:  1979-05-16       Impact factor: 3.786

7.  Neutral proteases capable of proteoglycan digesting activity in osteoarthritic and normal human articular cartilage.

Authors:  J Martel-Pelletier; J P Pelletier; J M Cloutier; D S Howell; L Ghandur-Mnaymneh; J F Woessner
Journal:  Arthritis Rheum       Date:  1984-03

8.  Collagenase and collagenase inhibitors in osteoarthritic and normal cartilage.

Authors:  M G Ehrlich; H J Mankin; H Jones; R Wright; C Crispen; G Vigliani
Journal:  J Clin Invest       Date:  1977-02       Impact factor: 14.808

9.  Hypertrophic repair of articular cartilage in experimental osteoarthrosis.

Authors:  E Vignon; M Arlot; D Hartmann; B Moyen; G Ville
Journal:  Ann Rheum Dis       Date:  1983-02       Impact factor: 19.103

10.  Metabolic response during early stages of surgically-induced osteoarthritis in mature beagles.

Authors:  E R Schwartz
Journal:  J Rheumatol       Date:  1980 Nov-Dec       Impact factor: 4.666

View more
  2 in total

1.  Genetic variation and causes of genotype-environment interaction in the body size of blue tit (Parus caeruleus).

Authors:  J Merilä; J D Fry
Journal:  Genetics       Date:  1998-03       Impact factor: 4.562

2.  Proteoglycan synthesis and osteophyte formation in 'metabolically' and 'mechanically' induced murine degenerative joint disease: an in-vivo autoradiographic study.

Authors:  P M van der Kraan; E L Vitters; H M van Beuningen; W B van den Berg
Journal:  Int J Exp Pathol       Date:  1992-06       Impact factor: 1.925

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.